MG53 alleviates hypoxia/reoxygenation-induced cardiomyocyte injury by succinylation and ubiquitination modification

References

• Orlandi M, Graziani F, D’Aiuto F. Periodontal therapy and cardiovascular risk. Periodontol. 2020;83(1):107–8. doi:10.1111/prd.12299.
   Google Scholar
• Jenca D, Melenovsky V, Stehlik J, Stanek V, Kettner J, Kautzner J, Adamkova V, Wohlfahrt P. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021;8(1):222–37. doi:10.1002/ehf2.13144.
   PubMed Web of Science ®Google Scholar
• Wan ANW, Mohamed MM, Chan BT, Lim E, Ahmad BA, Nik MN. The study of myocardial ischemia-reperfusion treatment through computational modelling. J Theor Biol. 2021;509:110527. doi:10.1016/j.jtbi.2020.110527.
   PubMed Web of Science ®Google Scholar
• Schafer A, Konig T, Bauersachs J, Akin M. Novel therapeutic strategies to reduce reperfusion injury After acute myocardial infarction. Curr Probl Cardiol. 2022;47(12):101398. doi:10.1016/j.cpcardiol.2022.101398.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ding L, Li Z, Zhou C. Structural basis for TRIM72 oligomerization during membrane damage repair. Nat Commun. 2023;14(1):1555. doi:10.1038/s41467-023-37198-1.
   PubMed Web of Science ®Google Scholar
• Wu HK, Zhang Y, Cao CM, Hu X, Fang M, Yao Y, Jin L, Chen G, Jiang P, Zhang S, et al. Glucose-sensitive myokine/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis. Circulation. 2019;139(7):901–14. doi:10.1161/CIRCULATIONAHA.118.037216.
   PubMed Web of Science ®Google Scholar
• Li H, Lin PH, Gupta P, Li X, Zhao SL, Zhou X, Li Z, Wei S, Xu L, Han R, et al. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer. Mol Cancer. 2021;20(1):118. doi:10.1186/s12943-021-01418-3.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang L, Yue H, Whitson BA, Haggard E, Xu X, Ma J. MG53, a tissue repair protein with broad applications in regenerative medicine. Cells. 2021;10(1):122. doi:10.3390/cells10010122.
   PubMed Web of Science ®Google Scholar
• Zhong W, Benissan-Messan DZ, Ma J, Cai C, Lee P. Cardiac effects and clinical applications of MG53. Cell & Bioscience. 2021;11(1):115. doi:10.1186/s13578-021-00629-x.
   PubMed Web of Science ®Google Scholar
• Lemckert FA, Bournazos A, Eckert DM, Kenzler M, Hawkes JM, Butler TL, Ceely B, North KN, Winlaw DS, Egan JR, et al. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor. Cardiovasc Res. 2016;110(2):178–87. doi:10.1093/cvr/cvw017.
   PubMed Web of Science ®Google Scholar
• Xie H, Wang Y, Zhu T, Feng S, Yan Z, Zhu Z, Ni J, Ni J, Du R, Zhu J, et al. Serum MG53/TRIM72 is associated with the presence and severity of coronary artery disease and acute myocardial infarction. Front Physiol. 2020;11:617845.
   PubMed Web of Science ®Google Scholar
• Xie H, Yan Z, Feng S, Zhu T, Zhu Z, Ni J, Ni J, Du R, Zhu J, Ding F, et al. Prognostic value of circulating MG53 levels in acute myocardial infarction. Front Cardiovasc Med. 2020;7:596107.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen M, Wang S, Yu L, Jiang H. MG53 protein: a promising novel therapeutic target for myocardial ischemia reperfusion injury. Int J Cardiol. 2015;199:424–25. doi:10.1016/j.ijcard.2015.07.084.
   PubMed Web of Science ®Google Scholar
• Wang S, Osgood AO, Chatterjee A. Uncovering post-translational modification-associated protein-protein interactions. Curr Opin Struct Biol. 2022;74:102352. doi:10.1016/j.sbi.2022.102352.
   PubMed Web of Science ®Google Scholar
• Walsh CT, Garneau-Tsodikova S, Gatto GJ. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem Int Ed Engl. 2005;44(45):7342–72. doi:10.1002/anie.200501023.
   PubMed Web of Science ®Google Scholar
• Toma-Fukai S, Shimizu T. Structural diversity of ubiquitin E3 ligase. Molecules. 2021;26(21):6682. doi:10.3390/molecules26216682.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y. Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol. 2011;7(1):58–63. doi:10.1038/nchembio.495.
   PubMed Web of Science ®Google Scholar
• Sreedhar A, Wiese EK, Hitosugi T. Enzymatic and metabolic regulation of lysine succinylation. Genes Dis. 2020;7(2):166–71. doi:10.1016/j.gendis.2019.09.011.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7(1):78. doi:10.1038/s41392-022-00925-z.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Lucchesi BR, Schaper J. Apoptosis in myocardial infarction. Ann Med. 2002;34(6):470–79. doi:10.1080/078538902321012414.
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Z, Ding Z, Mehta JL. Inflammation, autophagy, and apoptosis After myocardial infarction. J Am Heart Assoc. 2018;7(9). doi:10.1161/JAHA.117.008024.
   Web of Science ®Google Scholar
• Gumpper-Fedus K, Park KH, Ma H, Zhou X, Bian Z, Krishnamurthy K, Sermersheim M, Zhou J, Tan T, Li L, et al. MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress. Redox Biol. 2022;54:102357.
   PubMed Web of Science ®Google Scholar
• Wang Q, Park KH, Geng B, Chen P, Yang C, Jiang Q, Yi F, Tan T, Zhou X, Bian Z, et al. MG53 inhibits necroptosis through ubiquitination-dependent RIPK1 degradation for cardiac protection following ischemia/reperfusion injury. Front Cardiovasc Med. 2022;9:868632.
   PubMed Web of Science ®Google Scholar
• Zhao J, Lei H. Tripartite Motif protein 72 regulates the proliferation and migration of rat cardiac fibroblasts via the transforming growth factor-beta signaling pathway. Cardiology. 2016;134(3):340–46. doi:10.1159/000443703.
   PubMed Web of Science ®Google Scholar
• Yang L, Miao S, Zhang J, Wang P, Liu G, Wang J. The growing landscape of succinylation links metabolism and heart disease. Epigenomics. 2021;13(4):319–33. doi:10.2217/epi-2020-0273.
   PubMedGoogle Scholar
• Boylston JA, Sun J, Chen Y, Gucek M, Sack MN, Murphy E. Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury. J Mol Cell Cardiol. 2015;88:73–81. doi:10.1016/j.yjmcc.2015.09.005.
   PubMed Web of Science ®Google Scholar
• Kumar S, Lombard DB. Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology. Crit Rev Biochem Mol Biol. 2018;53(3):311–34. doi:10.1080/10409238.2018.1458071.
   PubMed Web of Science ®Google Scholar
• Zhou B, Du Y, Xue Y, Miao G, Wei T, Zhang P. Identification of malonylation, succinylation, and glutarylation in serum proteins of acute myocardial infarction patients. Proteomics Clin Appl. 2020;14(1):e1900103. doi:10.1002/prca.201900103.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gibson GE. Succinylation links metabolism to protein functions. Neurochem Res. 2019;44(10):2346–59. doi:10.1007/s11064-019-02780-x.
   PubMed Web of Science ®Google Scholar
• Ma X, Ma X, Zhu L, Zhao Y, Chen M, Li T, Lin Y, Ma D, Sun C, Han L. The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling. Oncogenesis. 2022;11(1):40. doi:10.1038/s41389-022-00414-6.
   PubMed Web of Science ®Google Scholar
• Yi JS, Park JS, Ham YM, Nguyen N, Lee NR, Hong J, Kim BW, Lee H, Lee CS, Jeong BC, et al. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun. 2013;4(1):2354. doi:10.1038/ncomms3354.
   PubMedGoogle Scholar
• Lv F, Wang Y, Shan D, Guo S, Chen G, Jin L, Zheng W, Feng H, Zeng X, Zhang S, et al. Blocking MG53S255 phosphorylation protects diabetic heart from ischemic injury. Circulation Research. 2022;131(12):962–76. doi:10.1161/CIRCRESAHA.122.321055.
   PubMed Web of Science ®Google Scholar